SSRI Tapering

Tapering Off SSRIs

SSRIs — selective serotonin reuptake inhibitors — are among the most commonly prescribed psychiatric medications in the world. Lexapro (escitalopram), Zoloft (sertraline), Prozac (fluoxetine), Paxil (paroxetine), and Celexa (citalopram) have been handed out for decades for depression, anxiety, OCD, panic disorder, and a long list of off-label uses. Most people who are prescribed them are never told what it might take to stop.

If you're here, you may already know that part firsthand.

Stopping an SSRI is not always the simple, gentle process the original prescribing conversation suggested. For some people it is. For many others, it isn't. And for a meaningful number of people, what happens after stopping — or after a too-fast taper — looks nothing like the brief "discontinuation symptoms" described in the package insert.

This page is for the people in that second group. The ones who tried to stop and ended up somewhere they didn't expect.

Why SSRIs Can Be Hard to Stop

SSRIs change how the brain handles serotonin. Over months and years on the medication, the nervous system adapts. Receptors downregulate. Signaling pathways shift. The brain is not the same brain it was before the medication was started — it has built itself around the presence of the drug.

When the medication comes off too quickly, the nervous system is left without the input it has adapted to expect. The result can be a wide range of symptoms that have nothing to do with the original condition the medication was prescribed for.

This is not a sign of weakness, addiction, or relapse. It is a physiological process. And the slower and more thoughtful the taper, the more room the nervous system has to readjust.

What Hyperbolic Tapering Means for SSRIs

Most standard tapering instructions reduce SSRI doses in equal steps — 20 mg, then 10 mg, then 5 mg, then stop. This sounds reasonable, but it ignores how SSRIs actually work in the brain.

The relationship between SSRI dose and serotonin transporter occupancy is not linear. At higher doses, large reductions affect only a small percentage of receptor binding. At lower doses, the same size reduction can affect a much larger percentage. This is why so many people sail through the first few cuts of a taper and then crash at the end — the final reductions are pharmacologically the biggest, even though they look like the smallest on paper.

Hyperbolic tapering accounts for this. Instead of equal milligram drops, the taper uses percentage-based reductions of the current dose, with smaller and smaller absolute amounts as the dose gets lower. For some people this means tapering down to fractions of a milligram before stopping. It can be done with liquid formulations, compounded doses, or careful use of tablet weighing — depending on the medication.

Hyperbolic tapering takes longer than standard tapers. Months. Sometimes a year or more. For people with longer medication histories or more sensitive nervous systems, longer still. The trade-off is fewer symptoms, more stability, and a much lower chance of ending up in protracted withdrawal.

Common Symptoms During an SSRI Taper

Withdrawal symptoms from SSRIs can show up in almost any body system. Some of the most commonly reported include:

• Brain zaps — brief electrical-feeling sensations in the head, often triggered by eye movement

• Anxiety that feels different from previous anxiety — more physical, more relentless

• Depression that feels chemical rather than situational

• Emotional blunting or numbness

• Irritability, rage, or mood swings that feel out of character

• Insomnia, vivid dreams, or fragmented sleep

• Dizziness, balance problems, or a sense of unsteadiness

• Nausea, appetite changes, or gastrointestinal upset

• Sensory sensitivity — sound, light, smell, or touch feeling overwhelming

• Headaches

• Flu-like symptoms

• Akathisia — an internal restlessness that makes it hard to sit still

• Cognitive symptoms — brain fog, memory issues, word-finding difficulty

Many people experience some of these. Some people experience many of them. The pattern varies, and the intensity varies. None of these symptoms mean something is wrong with the person experiencing them — they reflect a nervous system in the process of readjusting.

What Protracted Withdrawal Can Look Like

For most people, withdrawal symptoms resolve within weeks to a few months after the medication is stopped or stabilized. For a smaller but significant group, symptoms persist for many months or longer. The deprescribing literature refers to this as protracted withdrawal.

Protracted withdrawal often follows a windows-and-waves pattern. There are stretches of time — sometimes days, sometimes weeks — when symptoms ease and a person feels close to themselves again. Then a wave comes. Symptoms return, sometimes intensely, often with no clear trigger. The waves can be exhausting and demoralizing, especially when no one around the person understands what's happening.

This is one of the most commonly described patterns in the protracted withdrawal literature. It is also one of the most commonly misdiagnosed — frequently labeled as relapse, new-onset anxiety, treatment-resistant depression, or "something else going on."

A separate but related phenomenon affecting some people who have taken SSRIs is persistent sexual dysfunction after discontinuation. The deprescribing and post-SSRI literature describes a pattern of changes in libido, genital sensation, arousal, or emotional connection to intimacy that can continue after the medication is stopped. The frequency is not fully known. It is mentioned here because it is part of the picture for some people, and because being able to name it is often the first step toward not feeling alone with it.

How I Approach SSRI Tapering

My approach is built around four ideas.

First, stabilization before tapering. If a person is in acute withdrawal, in a wave, or recently destabilized by a too-fast taper, the first goal is stability — not more change. Tapering from an unstable place tends to make things worse.

Second, hyperbolic tapering when tapering is appropriate. Percentage-based reductions, sized to the individual, with adjustments based on how the nervous system responds. No rigid schedule. The taper follows the person, not a calendar.

Third, the whole person. Nutrition, sleep, movement, stress, nervous system regulation, and metabolic health all influence how a taper goes. Tapering in isolation, without attention to the rest of the system, is harder than it needs to be.

Fourth, informed consent — real informed consent. That means a clear conversation about what tapering may involve, what protracted withdrawal can look like, what is and isn't predictable, and what the alternatives are. No pressure to taper. No pressure not to. Decisions about whether and when to taper are made together, with the person fully informed.

Who This Is and Isn't a Fit For

This work is a fit for people who want a careful, slower approach to coming off an SSRI, who are willing to track symptoms and communicate during the process, and who are looking for a clinician who treats withdrawal as a real and known phenomenon rather than dismissing it.

It is not a fit for people in acute psychiatric crisis, people who need inpatient-level care, or people who are looking for a fast taper. It is also not a fit for people who want to start new psychiatric medications — this practice focuses on stabilization, tapering, and metabolic mental health, not on initiating new prescriptions.

Frequently Asked Questions

How long does an SSRI taper take?

There is no universal answer. For some people, several months is enough. For others, a year or more is appropriate. Length depends on the medication, the dose, how long it has been taken, the person's history with prior tapers, and how the nervous system responds along the way. A taper that is rushed to fit a timeline is the most common reason tapers go badly.

Can I taper an SSRI on my own?

Some people do, with good outcomes. Others do not. The risk of a self-directed taper is mostly in the rate of reduction and in not knowing what to do when symptoms appear. Working with a clinician who understands hyperbolic tapering does not guarantee a smooth process, but it does mean having someone to adjust the plan when the nervous system pushes back.

Is what I'm experiencing withdrawal or relapse?

This is one of the most common and most consequential questions in this work. Withdrawal and relapse can look similar on the surface, but they tend to differ in timing, in symptom features, and in how they respond to interventions. Many people who are told they are relapsing are actually in withdrawal, and the difference matters because the treatment for each is different. A careful history — when symptoms started, how they map to dose changes, what they actually feel like — is usually what sorts it out.

I'm on more than one medication. Can I still taper?

Yes, with care. Polypharmacy tapering is more complex but very common in this work. The order of tapering, the spacing between reductions, and the interaction between medications all need to be considered. Polypharmacy is one of the situations where individualized clinical oversight matters most.

What if I tried to stop in the past and it went badly?

That history is important and is not a sign that you can't taper successfully. It usually means the previous taper was too fast for your nervous system, and the next attempt needs a different plan. A failed prior taper is information, not a verdict.

Next Steps

If you live in Texas and want to talk about whether this approach is the right fit for you, the next step is a 15-minute discovery meeting. This is a brief conversation — not a clinical evaluation — to see if my approach feels like the right match for what you're looking for.

If you live outside Texas, I cannot provide clinical care, but I offer an education-only coaching membership that may be helpful as you work with your own prescriber.

Schedule a Discovery Meeting

Learn About Out-of-State Coaching

Other Medication Classes

• Tapering Off SNRIs

• Tapering Off Benzodiazepines

• Tapering Off Antipsychotics